摘要：In 1998 the author produced two papers which argued that consolidation was a necessary activity for biotechnology companies to consider more. Three years later a further consideration of the subject was published. Corporate developments in biotechnology in the first decade of the 21st century are now considered.
关键词：consolidation;merger;acquisition;business model
